Free Trial

Veeva Systems' (VEEV) Buy Rating Reaffirmed at BTIG Research

Veeva Systems logo with Medical background

Key Points

  • BTIG Research has reaffirmed a buy rating for Veeva Systems with a price target of $340.00, indicating a potential upside of 16.16% from its current price.
  • Veeva Systems recently reported quarterly earnings with a missed EPS estimate of $1.26 compared to the consensus of $1.90, but experienced a revenue increase of 16.7% year-over-year.
  • Institutional investors hold a significant stake in Veeva Systems, owning 88.20% of the company's stock, suggesting strong market confidence.
  • Interested in Veeva Systems? Here are five stocks we like better.

Veeva Systems (NYSE:VEEV - Get Free Report)'s stock had its "buy" rating restated by investment analysts at BTIG Research in a note issued to investors on Friday,Benzinga reports. They presently have a $340.00 price objective on the technology company's stock. BTIG Research's price target would suggest a potential upside of 16.16% from the stock's current price.

Other research analysts have also issued reports about the stock. Evercore ISI raised their target price on shares of Veeva Systems from $285.00 to $295.00 and gave the company an "in-line" rating in a research note on Thursday, August 28th. KeyCorp raised their target price on shares of Veeva Systems from $285.00 to $325.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. Oppenheimer reiterated an "outperform" rating and issued a $325.00 target price on shares of Veeva Systems in a research note on Thursday, August 28th. UBS Group raised their target price on shares of Veeva Systems from $285.00 to $310.00 and gave the company a "neutral" rating in a research note on Thursday, August 28th. Finally, Wells Fargo & Company raised their target price on shares of Veeva Systems from $300.00 to $326.00 and gave the company an "overweight" rating in a research note on Tuesday, August 26th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Veeva Systems presently has an average rating of "Moderate Buy" and an average target price of $307.58.

View Our Latest Research Report on Veeva Systems

Veeva Systems Stock Up 1.9%

VEEV stock opened at $292.71 on Friday. The company has a 50 day moving average of $283.41 and a two-hundred day moving average of $266.34. Veeva Systems has a 12-month low of $201.54 and a 12-month high of $310.50. The company has a market cap of $47.98 billion, a price-to-earnings ratio of 60.10, a PEG ratio of 2.22 and a beta of 0.98.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The business had revenue of $789.08 million for the quarter, compared to analyst estimates of $768.49 million. During the same quarter last year, the company earned $1.62 EPS. The business's revenue for the quarter was up 16.7% compared to the same quarter last year. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, research analysts anticipate that Veeva Systems will post 4.35 EPS for the current year.

Insider Buying and Selling at Veeva Systems

In related news, SVP Jonathan Faddis sold 720 shares of the business's stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $298.12, for a total transaction of $214,646.40. Following the completion of the sale, the senior vice president directly owned 7,868 shares of the company's stock, valued at $2,345,608.16. The trade was a 8.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the business's stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the sale, the insider directly owned 25,325 shares of the company's stock, valued at approximately $7,765,151.50. This trade represents a 19.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 24,665 shares of company stock worth $7,438,000. 10.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Trust Co. of Toledo NA OH acquired a new position in Veeva Systems during the second quarter valued at approximately $29,000. Abound Financial LLC acquired a new position in shares of Veeva Systems in the first quarter valued at approximately $25,000. Legacy Investment Solutions LLC acquired a new position in shares of Veeva Systems in the second quarter valued at approximately $32,000. ORG Partners LLC acquired a new position in shares of Veeva Systems in the first quarter valued at approximately $26,000. Finally, Maseco LLP acquired a new position in shares of Veeva Systems in the second quarter valued at approximately $35,000. Institutional investors and hedge funds own 88.20% of the company's stock.

Veeva Systems Company Profile

(Get Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Featured Articles

Analyst Recommendations for Veeva Systems (NYSE:VEEV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veeva Systems Right Now?

Before you consider Veeva Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veeva Systems wasn't on the list.

While Veeva Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.